Inebilizumab Effective Up to 52 Weeks in Myasthenia Gravis ...Middle East

Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with generalized myasthenia gravis, a phase 3 trial suggests. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Inebilizumab Effective Up to 52 Weeks in Myasthenia Gravis )

Also on site :

• Who Is FSU Shooting Suspect Phoenix Ikner? What We Know
• Man shot and killed by police in Golden Hill this week identified as Enrique Cortez, 37
• Iran responds to Trump: We’ll defend ourselves